Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Hot Flashes 1Endometrial Neoplasms 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1

Interventions

Tamoxifen 6Radiotherapy 3Anastrozole 3Medroxyprogesterone 2Letrozole 2Chemotherapy, Adjuvant 2pembrolizumab 1oxybutynin 1exemestane 1Watchful Waiting 1Specimen Handling 1Risedronic Acid 1Radiation 1Psychiatric Rehabilitation 1Observation 1Norethindrone Acetate 1Mometasone Furoate 1Metformin 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Fentanyl 1Estrogens, Conjugated (USP) 1Estradiol 1Early Intervention, Educational 1Counseling 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Carcinoma In Situ × Estrogens, Conjugated (USP) × Clear all
NCT00026286 2023-06-15

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡